NASDAQ: CRMETSX: COM VANCOUVER, Sept. 8, 2015 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME /TSX: COM ) today announced that Robert James Meyer, M.D. has joined its board of directors. Dr. Meyer joins Cardiome's board with over 30 years of leadership experience in academic, industry and government agencies, specifically in roles that have direct relevance to Cardiome and its clinical and commercial programs. Dr Meyer is currently a Director at the Virginia Center for Translational and Regulatory Sciences at the University of Virginia School of Medicine, but has held senior roles at Merck Research Laboratories from 2007 to 2013, most recently as Vice President, Global Regulatory Strategy, Policy and Safety, as well as at the U.S. Food and Drug Administration (FDA) from 1999 to 2007 where Dr. Meyer served as Director of the Division of Pulmonary and Allergy Drug Products and then Director of the Office of Drug Evaluation II in the Center for Drug Evaluation and Research.